Peptides for Microbe-induced Cancers: Latest Therapeutic Strategies and Their Advanced Technologies

Overview

Journal Cancer Metastasis Rev

Specialty Oncology

Date 2024 Jul 15

PMID 39008152

Authors

Ziqi Lin

Yehuda G Assaraf

Hang Fai Kwok

Affiliations

Soon will be listed here.

Abstract

Cancer is a significant global health concern associated with multiple distinct factors, including microbial and viral infections. Numerous studies have elucidated the role of microorganisms, such as Helicobacter pylori (H. pylori), as well as viruses for example human papillomavirus (HPV), hepatitis B virus (HBV), and hepatitis C virus (HCV), in the development of human malignancies. Substantial attention has been focused on the treatment of these microorganism- and virus-associated cancers, with promising outcomes observed in studies employing peptide-based therapies. The current paper provides an overview of microbe- and virus-induced cancers and their underlying molecular mechanisms. We discuss an assortment of peptide-based therapies which are currently being developed, including tumor-targeting peptides and microbial/viral peptide-based vaccines. We describe the major technological advancements that have been made in the design, screening, and delivery of peptides as anticancer agents. The primary focus of the current review is to provide insight into the latest research and development in this field and to provide a realistic glimpse into the future of peptide-based therapies for microbe- and virus-induced neoplasms.

References

Zong X, Fu J, Xu B, Wang Y, Jin M . Interplay between gut microbiota and antimicrobial peptides. Anim Nutr. 2020; 6(4):389-396. PMC: 7750803. DOI: 10.1016/j.aninu.2020.09.002. View

Aas J, Paster B, Stokes L, Olsen I, Dewhirst F . Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43(11):5721-32. PMC: 1287824. DOI: 10.1128/JCM.43.11.5721-5732.2005. View

Man W, de Steenhuijsen Piters W, Bogaert D . The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017; 15(5):259-270. PMC: 7097736. DOI: 10.1038/nrmicro.2017.14. View

Kumpitsch C, Koskinen K, Schopf V, Moissl-Eichinger C . The microbiome of the upper respiratory tract in health and disease. BMC Biol. 2019; 17(1):87. PMC: 6836414. DOI: 10.1186/s12915-019-0703-z. View

Sanford J, Gallo R . Functions of the skin microbiota in health and disease. Semin Immunol. 2013; 25(5):370-7. PMC: 4219649. DOI: 10.1016/j.smim.2013.09.005. View

de Martel C, Georges D, Bray F, Ferlay J, Clifford G . Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2019; 8(2):e180-e190. DOI: 10.1016/S2214-109X(19)30488-7. View

Hleihel R, Akkouche A, Skayneh H, Hermine O, Bazarbachi A, El Hajj H . Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities. Curr Oncol Rep. 2021; 23(12):141. DOI: 10.1007/s11912-021-01138-3. View

Polk D, Peek Jr R . Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010; 10(6):403-14. PMC: 2957472. DOI: 10.1038/nrc2857. View

Muttenthaler M, King G, Adams D, Alewood P . Trends in peptide drug discovery. Nat Rev Drug Discov. 2021; 20(4):309-325. DOI: 10.1038/s41573-020-00135-8. View

10.

Jia L, Gao Y, He Y, Hooper J, Yang P . HBV induced hepatocellular carcinoma and related potential immunotherapy. Pharmacol Res. 2020; 159:104992. DOI: 10.1016/j.phrs.2020.104992. View

11.

Serup-Hansen E, Linnemann D, Skovrider-Ruminski W, Hogdall E, Geertsen P, Havsteen H . Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal. J Clin Oncol. 2014; 32(17):1812-7. DOI: 10.1200/JCO.2013.52.3464. View

12.

Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F . A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy. Adv Sci (Weinh). 2023; 10(15):e2207366. PMC: 10214247. DOI: 10.1002/advs.202207366. View

13.

Bessede E, Megraud F . Microbiota and gastric cancer. Semin Cancer Biol. 2022; 86(Pt 3):11-17. DOI: 10.1016/j.semcancer.2022.05.001. View

14.

Cohen L, Livney Y, Assaraf Y . Targeted nanomedicine modalities for prostate cancer treatment. Drug Resist Updat. 2021; 56:100762. DOI: 10.1016/j.drup.2021.100762. View

15.

Xuan C, Shamonki J, Chung A, DiNome M, Chung M, Sieling P . Microbial dysbiosis is associated with human breast cancer. PLoS One. 2014; 9(1):e83744. PMC: 3885448. DOI: 10.1371/journal.pone.0083744. View

16.

Floch P, Megraud F, Lehours P . Helicobacter pylori Strains and Gastric MALT Lymphoma. Toxins (Basel). 2017; 9(4). PMC: 5408206. DOI: 10.3390/toxins9040132. View

17.

De Almeida C, Taddei A, Amedei A . The controversial role of in colorectal cancer. Therap Adv Gastroenterol. 2018; 11:1756284818783606. PMC: 6044108. DOI: 10.1177/1756284818783606. View

18.

Premachandra N, Jayaweera J . Chlamydia pneumoniae infections and development of lung cancer: systematic review. Infect Agent Cancer. 2022; 17(1):11. PMC: 8941765. DOI: 10.1186/s13027-022-00425-3. View

19.

Yuan Y, Cai X, Shen F, Ma F . HPV post-infection microenvironment and cervical cancer. Cancer Lett. 2020; 497:243-254. DOI: 10.1016/j.canlet.2020.10.034. View

20.

Doorbar J . Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006; 110(5):525-41. DOI: 10.1042/CS20050369. View